Clinicopathological and therapeutic patterns of idiopathic pulmonary fibrosis in Kuwait: A prospective study

Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait.
International Journal of Clinical Practice (Impact Factor: 2.57). 01/2004; 57(10):879-84.
Source: PubMed


Though common, the exact incidence and clinical pattern of idiopathic pulmonary fibrosis (IPF) in Gulf countries are not known. The results of a four-year prospective study undertaken in two tertiary hospitals in Kuwait are presented. The mean age at diagnosis of the 52 patients studied was 55.40 +/- 11.87 years. Thirty-two (61.5%) patients were male and 22 (42.3%) were smokers. The mean duration of symptoms at diagnosis was 2.1 +/- 0.92 years. Digital clubbing was found in 34 (65%) patients. The mean FVC, TLC and TLCO were 57%, 64.4% and 55% of predicted normal, respectively. The FVC value showed a significant difference between smokers and non-smokers (p < 0.05). HRCT findings were abnormal in all patients. Typical histological and high-resolution computed tomography findings of usual interstitial pneumonia, desquamative interstitial pneumonia and non-specific interstitial pneumonia were observed. This study revealed that IPF is prevalent in Kuwait, with patterns showing some similarities to those established elsewhere. The response to treatment was not encouraging, especially in the usual interstitial pneumonia subtype.

3 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: IPF is the most common form of interstitial lung disease. IPF is a clinico-pathological syndrome characterized by cough, exertional dyspnea, basilar crackles, a restrictive pattern on pulmonary function test (PFT) and honey comb pattern on HRCT. Since there are no exact data on IPF in Iranian patients and also the controversy that exist in this regard we decided to study the IPF cases in regard to epidemiologic, clinical features, radiologic manifestations and diagnosis in Masih Daneshvari Hospital during 1998-2001. Materials and Methods: This study was a descriptive retrospective study on files of IPF patients in Masih Daneshvari Hospital during 1998-2001. Although the total number of patients was 98, only 50 cases that had clinical and pathological findings compatible with IPF were included in the study. Results: Twenty-seven (54%) were males and 23 (46%) were females. Mean age was 56.25 ±15.86 yrs. The most common clinical signs and symptoms were dyspnea (100%), cough (90%) and crackle (90%). HRCT findings were abnormal in all patients. Eighteen percent were smokers and the most common occupational exposure was through agriculture. 82.2% of patients had restrictive pattern on PFT. Seventy percent of patients had transbronchial lung biopsy (TBLB), 26% had open lung biopsy (OLB) and 4% had video-assisted thoracoscopy (VATS). Conclusion : Age of patients with IPF in our study is one decade lower than in Western countries. HRCT and TBLB assist significantly in the diagnosis of IPF and limiting the surgical procedures to only a limited number of cases. (Tanaffos 2006; 5(2): 27-32)
    Tanaffos 01/2006; 5(2).
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The spectrum of pulmonary pathology in the Middle East is as versatile as its civilizations and cultures. In this review, we outline the key challenges confronting pulmonologists in the Middle East. We shed light on the diverse conditions commonly encountered in the region, from the centuries-old illnesses of tuberculosis, to contemporary problems such as lung complications from chemical warfare. We specifically highlighted unique aspects related to respiratory illnesses in the Middle East, for example, climate factors in the desert region, cultural habits, for example, water-pipe smoking and disorders unique to the region, such as Behçet's disease. Pulmonologists are also faced with the consequences of modernization, including large immigrant population and associated social and health issues, rising incidence of obesity and sleep apnoea, and drug-resistant tuberculosis. Tackling these health issues will require an integrated approach involving public health, primary care as well as specialist pulmonology input, taking into consideration the unique cultural and environmental factors to ensure effective management and compliance to medical care.
    Respirology 05/2011; 16(5):755-66. DOI:10.1111/j.1440-1843.2011.01988.x · 3.35 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The incidence of idiopathic pulmonary fibrosis (IPF) appears to be increasing. In the western literature, the average age of presentation is in the seventh decade of life while it has been reported to be earlier in the Middle East and India. Given that a paucity of epidemiological data exists in Iran, we sought to describe the clinical pattern and course of the disease at a large Iranian referral center. A retrospective review was conducted of 132 patients diagnosed with IPF at the National Research Institute of Tuberculosis and Lung Diseases (NRITLD) in Tehran, Iran from 1988 through 2008. Data were collected from the medical records which consisted of demographics, clinical history, laboratory tests, pulmonary function tests (PFT), radiographic and pathology findings, treatment, and outcomes of the disease. The mean age at diagnosis was 56.6 years (95% CI: 53.8 - 59.4) with no significant sex predilection. Common presenting symptoms included dyspnea and cough, which occurred for a mean period of 21 months prior to diagnosis. Common signs included end-inspiratory crackles and digital clubbing, which were found in 85.6% and 55.3% of the patients, respectively. Radiographically, reticular and reticulonodular opacities were seen in 47.3% and 20.9% of the patients, respectively on high resolution computed tomography (HRCT). In patients who underwent lung biopsy, diffuse interstitial fibrosis was seen in 91.1%. The mean follow-up time for all patients was 32.8 months (95% CI: 23.2 - 42.4, range: 1 - 257 months). There were 16 patients who died during the study period. The mean age of death was 56.8 years (95% CI: 46.2 - 67.4), which is significantly lower than the life expectancy in Iran (P-value: 0.017). The mean survival time for patients who died was 1.1 years (95% CI: 0.5 - 1.7) after diagnosis. The one- and three- year overall survival rates for all patients were 88% and 79%, respectively. The clinical characteristics of IPF in Iran are similar to those in the western literature. However, Iranian patients appear to be developing the disease a decade earlier than western patients.
    Archives of Iranian medicine 03/2013; 16(3):177-81. · 1.11 Impact Factor